TSXV:PLRB - Pluribus Technologies
Trending >
iA Capital initiates coverage of MediaValet with a Buy rating

The stock got kicked around last year for a considerable loss, but there are better times ahead for Canadian digital asset management name MediaValet (MediaValet Stock Quote, Charts, News, Analysts, Financials TSX:MVP), according to iA Capital Markets analyst Neehal Upadhyaya,... Keep reading

Medexus Pharmaceuticals has Outperform rating with Raymond James
POINT Biopharma keeps Outperform rating with Raymond James
Organigram has an 82 per cent upside, says Raymond James

STOCK PICKS

More STOCK PICKS →
NowVertical keeps Buy rating with Beacon

Investment bankers Beacon Securities has reiterated a “Buy” rating on Canadian analytics stock NowVertical Group (NowVertical Group Stock Quote, Charts,... Read More

Kraken Robotics has a 78 per cent upside, says Beacon

Fans of Kraken Robotics (Kraken Robotics Stock Quote, Charts, News, Analysts, Financials TSXV:PNG) can look forward to a great year... Read More

LIFE SCIENCES STOCKS

More LIFE SCIENCES STOCKS →
Microbix
Microbix has an upside of 136 per cent, Industrial Alliance says

A new development at Microbix Biosystems (Microbix Systems Stock Quote, Chart, News, Analysts, Financials TSX:MBX) has Industrial Alliance Securities analyst... Read More

We’re still bullish on Opsens, says Raymond James

With a healthy cash position and improving numbers, Raymond James analyst Rahul Sarugaser says he’s still very bullish on Opsens... Read More

Six Top Picks for your stock portfolio from iA Capital

It’s been a rough first half of the year but steely-eyed investors on the lookout for good ideas have a... Read More

Timely, Pro Stock Picks, In Your Inbox.

Organigram receives target reduction from Raymond James

Continuing market share gains in Canada’s cannabis trade look good on Moncton, New Brunswick-based Organigram Holdings (Organigram Stock Quote, Charts,... Read More

Two top cannabis picks from Echelon Capital

The sector may still be down in the dumps, but investors should see better times ahead in the cannabis space... Read More

Tilray is still a pass, says Haywood

New quarterly results from cannabis company Tilray Brands (Tilray Brands Stock Quote, Charts, News, Analysts, Financials TSX:TLRY) weren’t enough to... Read More

TRENDING STORIES

All TRENDING NEWS →
Kits Eyecare keeps Buy rating with Roth

After releasing preliminary fourth quarter numbers, Kits Eyecare (Kits Eyecare Stock Quote, Charts, News, Analysts, Financials TSX:KITS) is still a... Read More

Thinkific is heading to $4.00, says National Bank

National Bank Financial analyst Richard Tse isn’t fazed by a headcount reduction announcement from Canadian online learning platform Thinkific Labs... Read More

Three Top Picks from Haywood Capital

Investment bankers Haywood Capital Markets released its 2023 Best Ideas report on Wednesday, saying there are enough macro factors at... Read More

Bull Market
Nine top stock picks from Echelon Capital

Volatility has been the name of the game recently, especially for growth stocks, but investors with enough fortitude should lean... Read More

Zedcor wins target raise from Paradigm

Paradigm Capital analyst Alexandra Ricci is staying bullish on Canadian security tech company Zedcor Inc (Zedcor Stock Quote, Charts, News,... Read More

Sernova
Sernova has a 255 per cent upside, says Leede Jones Gable

Leede Jones Gable analyst Douglas W. Loe kept a “Speculative Buy” rating on med tech company Sernova Corp (Sernova Stock... Read More

ATS Corp scores target raise from Stifel

Record backlog and bookings have baked in growth for ATS Corp (ATS Corporation Stock Quote, Charts, News, Analysts, Financials TSX:ATS),... Read More

WELL Health has a 361 per cent upside, says Stifel

Stifel GMP analyst Justin Keywood renewed a “Buy” rating on WELL Health Technologies (WELL Health Technologies Stock Quote, Charts, News,... Read More

Calian Group
Calian Group is a Top Pick, says Echelon

It’s full speed ahead for Calian Group (Calian Group Stock Quote, Charts, News, Analysts, Financials TSX:CGY), according to Echelon Capital... Read More

Two Healthcare stock picks from Echelon

Echelon Capital Markets analyst Stefan Quenneville delivered updates on Tuesday on two healthcare stocks — Diagnos Inc (Diagnos Stock Quote,... Read More

Three top tech picks for Q1 2023

Echelon Capital Markets analyst Rob Goff is sticking with his guns on a trio of tech stock picks for the... Read More

Top Tech stock picks for 2023 from Eight Capital

Investment bankers Eight Capital published on Tuesday a report outlining their top sector picks for the new year, with three... Read More

Canada Stock Investment Guides

More STOCK GUIDES →

It’s hard to argue with success. All around, 2021 has been pretty outstanding for Canadian stocks,...

So you are a Canadian looking to put some money to work for yourself in the stock market. Or perhaps...

ASEP